Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

The management of patients with chronic myeloid leukemia (CML) has been revolutionized by the introduction of tyrosine kinase inhibitors (TKIs), which induce deep molecular responses so that treatment can eventually be discontinued, leading to treatment-free remission (TFR) in a subset of patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobi, Henrike, Vieri, Margherita, Bütow, Marlena, Namasu, Carolina Y., Flüter, Laura, Costa, Ivan G., Maié, Tiago, Lindemann-Docter, Katharina, Chatain, Nicolas, Beier, Fabian, Huber, Michael, Wagner, Wolfgang, Crysandt, Martina, Brümmendorf, Tim H., Schemionek, Mirle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352620/
https://www.ncbi.nlm.nih.gov/pubmed/37469867
http://dx.doi.org/10.3389/fphar.2023.1212392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352620/
https://www.ncbi.nlm.nih.gov/pubmed/37469867
http://dx.doi.org/10.3389/fphar.2023.1212392

Ejemplares similares